Position in KROS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,122,958
-$258,113 QoQ
Shares Held
759,155
0.0% QoQ
Ownership
3.83%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#5
of 131 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KROS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ORBIMED ADVISORS LLC holds $3,639,640,835 across 90 Biotechnology names. KROS ranks #60 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
15,518,492 | $630,516,329 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
6,776,632 | $343,914,074 | |
| 3 | MBX |
MBX Biosciences, Inc.
|
3,428,736 | $189,266,227 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
2,209,400 | $118,578,498 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
2,555,877 | $112,433,029 | |
| 6 | CRVS |
Corvus Pharmaceuticals, Inc.
|
7,165,006 | $107,045,189 | |
| 7 | AVBP |
ArriVent BioPharma, Inc.
|
3,027,328 | $105,169,374 | |
| 8 | ARGX |
Argenx SE
|
92,880 | $86,171,277 |
All Filings in KROS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,122,958 | 759,155 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,381,071 | 759,155 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,373,756 | 804,212 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $16,116,371 | 1,018,734 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,600,098 | 1,018,734 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,380,899 | 1,018,734 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $16,126,559 | 1,018,734 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $59,157,883 | 1,018,734 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $57,981,143 | 1,268,734 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $83,990,190 | 1,268,734 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $50,444,863 | 1,268,734 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $48,289,719 | 1,514,734 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $60,862,012 | 1,514,734 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $71,711,105 | 1,679,417 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $80,645,604 | 1,679,417 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $63,179,667 | 1,679,417 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $46,402,291 | 1,679,417 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $91,326,696 | 1,679,417 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $98,262,688 | 1,679,417 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $66,437,736 | 1,679,417 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $71,324,839 | 1,679,417 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $103,368,116 | 1,679,417 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $118,466,075 | 1,679,417 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $64,775,113 | 1,679,417 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $62,994,931 | 1,679,417 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||